OBJECTIVES/HYPOTHESIS: Dehydration of airway surface liquid (ASL) disrupts normal mucociliary clearance in sinonasal epithelium leading to chronic rhinosinusitis. Abnormal chloride (Cl(-)) transport is one mechanism that contributes to this disorder, as demonstrated by the disease cystic fibrosis. Identifying safe compounds that stimulate transepithelial Cl(-) transport is critical to improving hydration of the ASL and promoting mucociliary transport. Sinupret (Bionorica, LLC, San Clemente, CA), a combination of naturally occurring bioflavonoids, is a widely used treatment for respiratory ailments in Europe. However, the effects of Sinupret on target respiratory epithelium have yet to be fully investigated. The present study evaluated the mechanisms underlying this bioflavonoid therapeutic on transepithelial Cl(-) transport in respiratory epithelium. STUDY DESIGN: In vitro and in vivo investigation. METHODS: Well characterized murine nasal septal epithelial (MNSE) cultures, and murine nasal potential difference (NPD) techniques were used to evaluate the effects of Sinupret on Cl(-) secretion. RESULTS: The change in Sinupret-stimulated current (Delta I(SC) expressed as microA/cm(2)) in MNSE, representing Cl(-) secretion, was significantly increased when compared to controls (19.04 + or - 1.67 microA/cm(2) vs. 1.8 + or - 0.35 microA/cm(2), respectively; P = .00005). Transepithelial Cl(-) transport measured in the murine NPD in vivo assay (n = 42) was also significantly enhanced when compared to controls (-0.8 mV vs. -0.9 mV; P = .0004). Importantly, Sinupret-stimulated Cl(-) transport was substantially more robust in vivo than forskolin, a compound among the strongest known cystic fibrosis transmembrane conductance regulator activators (-3.8 mV vs. -1.65 mV; P = .01). CONCLUSIONS: Sinupret strongly activates transepithelial Cl(-) secretion through a mechanism known to hydrate the ASL of respiratory epithelium. This is one means by which the medication is likely to exert therapeutic benefit.
OBJECTIVES/HYPOTHESIS: Dehydration of airway surface liquid (ASL) disrupts normal mucociliary clearance in sinonasal epithelium leading to chronic rhinosinusitis. Abnormal chloride (Cl(-)) transport is one mechanism that contributes to this disorder, as demonstrated by the disease cystic fibrosis. Identifying safe compounds that stimulate transepithelial Cl(-) transport is critical to improving hydration of the ASL and promoting mucociliary transport. Sinupret (Bionorica, LLC, San Clemente, CA), a combination of naturally occurring bioflavonoids, is a widely used treatment for respiratory ailments in Europe. However, the effects of Sinupret on target respiratory epithelium have yet to be fully investigated. The present study evaluated the mechanisms underlying this bioflavonoid therapeutic on transepithelial Cl(-) transport in respiratory epithelium. STUDY DESIGN: In vitro and in vivo investigation. METHODS: Well characterized murine nasal septal epithelial (MNSE) cultures, and murine nasal potential difference (NPD) techniques were used to evaluate the effects of Sinupret on Cl(-) secretion. RESULTS: The change in Sinupret-stimulated current (Delta I(SC) expressed as microA/cm(2)) in MNSE, representing Cl(-) secretion, was significantly increased when compared to controls (19.04 + or - 1.67 microA/cm(2) vs. 1.8 + or - 0.35 microA/cm(2), respectively; P = .00005). Transepithelial Cl(-) transport measured in the murine NPD in vivo assay (n = 42) was also significantly enhanced when compared to controls (-0.8 mV vs. -0.9 mV; P = .0004). Importantly, Sinupret-stimulated Cl(-) transport was substantially more robust in vivo than forskolin, a compound among the strongest known cystic fibrosis transmembrane conductance regulator activators (-3.8 mV vs. -1.65 mV; P = .01). CONCLUSIONS: Sinupret strongly activates transepithelial Cl(-) secretion through a mechanism known to hydrate the ASL of respiratory epithelium. This is one means by which the medication is likely to exert therapeutic benefit.
Authors: Christopher Azbell; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth Journal: Otolaryngol Head Neck Surg Date: 2010-09 Impact factor: 3.497
Authors: Nathan S Alexander; Neal Hatch; Shaoyan Zhang; Daniel Skinner; James Fortenberry; Eric J Sorscher; Bradford A Woodworth Journal: Laryngoscope Date: 2011-04-07 Impact factor: 3.325
Authors: Shaoyan Zhang; Nicholas Smith; Daniel Schuster; Christopher Azbell; Eric J Sorscher; Steven M Rowe; Bradford A Woodworth Journal: Am J Rhinol Allergy Date: 2011 Sep-Oct Impact factor: 2.467
Authors: Do-Yeon Cho; Daniel Skinner; Calvin Mackey; Harold B Lampkin; Jeffrey Brent Elder; Dong Jin Lim; Shaoyan Zhang; Justin McCormick; Guillermo J Tearney; Steven M Rowe; Bradford A Woodworth Journal: Int Forum Allergy Rhinol Date: 2019-01-18 Impact factor: 3.858
Authors: Do-Yeon Cho; Daniel Skinner; Shaoyan Zhang; James Fortenberry; Eric J Sorscher; Nichole R Dean; Bradford A Woodworth Journal: Int Forum Allergy Rhinol Date: 2015-12-03 Impact factor: 3.858
Authors: Nathan S Alexander; Angela Blount; Shaoyan Zhang; Daniel Skinner; Stephen B Hicks; Michael Chestnut; Frederick A Kebbel; Eric J Sorscher; Bradford A Woodworth Journal: Laryngoscope Date: 2012-04-20 Impact factor: 3.325
Authors: Angela Blount; Shaoyan Zhang; Michael Chestnut; Brian Hixon; Daniel Skinner; Eric J Sorscher; Bradford A Woodworth Journal: Laryngoscope Date: 2011-08-16 Impact factor: 3.325
Authors: Benjamin M Hariri; Sakeena J Payne; Bei Chen; Corrine Mansfield; Laurel J Doghramji; Nithin D Adappa; James N Palmer; David W Kennedy; Masha Y Niv; Robert J Lee Journal: Am J Rhinol Allergy Date: 2016-07 Impact factor: 2.467